Structure

Physi-Chem Properties

Molecular Weight:  496.36
Volume:  555.701
LogP:  6.244
LogD:  4.849
LogS:  -5.644
# Rotatable Bonds:  7
TPSA:  63.6
# H-Bond Aceptor:  4
# H-Bond Donor:  1
# Rings:  3
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.182
Synthetic Accessibility Score:  4.816
Fsp3:  0.688
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.718
MDCK Permeability:  2.3929909730213694e-05
Pgp-inhibitor:  0.997
Pgp-substrate:  0.8
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.593
30% Bioavailability (F30%):  0.555

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.416
Plasma Protein Binding (PPB):  93.37010955810547%
Volume Distribution (VD):  1.801
Pgp-substrate:  5.221670150756836%

ADMET: Metabolism

CYP1A2-inhibitor:  0.033
CYP1A2-substrate:  0.083
CYP2C19-inhibitor:  0.205
CYP2C19-substrate:  0.857
CYP2C9-inhibitor:  0.397
CYP2C9-substrate:  0.09
CYP2D6-inhibitor:  0.396
CYP2D6-substrate:  0.16
CYP3A4-inhibitor:  0.729
CYP3A4-substrate:  0.578

ADMET: Excretion

Clearance (CL):  5.048
Half-life (T1/2):  0.037

ADMET: Toxicity

hERG Blockers:  0.768
Human Hepatotoxicity (H-HT):  0.816
Drug-inuced Liver Injury (DILI):  0.249
AMES Toxicity:  0.008
Rat Oral Acute Toxicity:  0.628
Maximum Recommended Daily Dose:  0.985
Skin Sensitization:  0.942
Carcinogencity:  0.229
Eye Corrosion:  0.004
Eye Irritation:  0.017
Respiratory Toxicity:  0.973

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC266955

Natural Product ID:  NPC266955
Common Name*:   Stelliferin A
IUPAC Name:   [(3Z,3aS,5aR,7S,9aR,9bS)-3-[(3E,5E,7S)-7-hydroxy-6,10-dimethylundeca-3,5,9-trien-2-ylidene]-3a,6,6,9a-tetramethyl-2-oxo-1,4,5,5a,7,8,9,9b-octahydrocyclopenta[a]naphthalen-7-yl] acetate
Synonyms:  
Standard InCHIKey:  JQQLGYJOHJVUFP-SOBFQGAKSA-N
Standard InCHI:  InChI=1S/C32H48O4/c1-20(2)13-14-24(34)21(3)11-10-12-22(4)29-25(35)19-27-31(8)18-16-28(36-23(5)33)30(6,7)26(31)15-17-32(27,29)9/h10-13,24,26-28,34H,14-19H2,1-9H3/b12-10+,21-11+,29-22+/t24-,26-,27-,28-,31-,32-/m0/s1
SMILES:  CC(=CC[C@@H](/C(=C/C=C/C(=C/1C(=O)C[C@H]2[C@@]3(C)CC[C@@H](C(C)(C)[C@@H]3CC[C@]12C)OC(=O)C)/C)/C)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL481847
PubChem CID:   10074564
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO10924 Stelletta globostellata Species Ancorinidae Eukaryota n.a. n.a. n.a. PMID[10691710]
NPO10924 Stelletta globostellata Species Ancorinidae Eukaryota n.a. Kubat, Malaysia 1991 PMID[18327911]
NPO10924 Stelletta globostellata Species Ancorinidae Eukaryota n.a. n.a. n.a. PMID[18327911]
NPO10924 Stelletta globostellata Species Ancorinidae Eukaryota n.a. n.a. n.a. PMID[8778241]
NPO10924 Stelletta globostellata Species Ancorinidae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT168 Cell Line P388 Mus musculus GI50 = 21.0 nM PMID[544625]
NPT27 Others Unspecified GI50 = 34.0 nM PMID[544625]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC266955 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9892 High Similarity NPC115899
0.9579 High Similarity NPC32577
0.9579 High Similarity NPC155332
0.9579 High Similarity NPC114540
0.9462 High Similarity NPC250757
0.9462 High Similarity NPC301534
0.9388 High Similarity NPC473284
0.9278 High Similarity NPC72151
0.9263 High Similarity NPC108368
0.9263 High Similarity NPC57079
0.9247 High Similarity NPC474690
0.9175 High Similarity NPC320447
0.9158 High Similarity NPC110937
0.9082 High Similarity NPC475526
0.9082 High Similarity NPC475050
0.9082 High Similarity NPC473283
0.9082 High Similarity NPC329345
0.9072 High Similarity NPC282524
0.9053 High Similarity NPC471153
0.9043 High Similarity NPC299100
0.9032 High Similarity NPC474018
0.9032 High Similarity NPC473986
0.901 High Similarity NPC475065
0.8958 High Similarity NPC474938
0.8958 High Similarity NPC474785
0.8947 High Similarity NPC88310
0.8947 High Similarity NPC180950
0.8925 High Similarity NPC475965
0.8925 High Similarity NPC474842
0.8911 High Similarity NPC473482
0.8911 High Similarity NPC318363
0.8911 High Similarity NPC475418
0.89 High Similarity NPC266570
0.8842 High Similarity NPC471078
0.8842 High Similarity NPC473280
0.8842 High Similarity NPC473431
0.8842 High Similarity NPC473435
0.8812 High Similarity NPC329048
0.8812 High Similarity NPC330011
0.8804 High Similarity NPC141292
0.8776 High Similarity NPC35751
0.8763 High Similarity NPC141401
0.8763 High Similarity NPC253826
0.871 High Similarity NPC310752
0.871 High Similarity NPC292491
0.8687 High Similarity NPC99411
0.8687 High Similarity NPC476223
0.8687 High Similarity NPC194028
0.8687 High Similarity NPC476240
0.8687 High Similarity NPC224720
0.8687 High Similarity NPC118174
0.8687 High Similarity NPC168319
0.8673 High Similarity NPC478056
0.8654 High Similarity NPC474315
0.8646 High Similarity NPC469406
0.8641 High Similarity NPC10064
0.8641 High Similarity NPC170221
0.8617 High Similarity NPC36668
0.8617 High Similarity NPC118011
0.86 High Similarity NPC136289
0.8586 High Similarity NPC476274
0.8571 High Similarity NPC320306
0.8571 High Similarity NPC2049
0.8571 High Similarity NPC108078
0.8558 High Similarity NPC6206
0.8542 High Similarity NPC38232
0.8529 High Similarity NPC189863
0.8526 High Similarity NPC48010
0.8526 High Similarity NPC477149
0.8526 High Similarity NPC477147
0.8526 High Similarity NPC471896
0.8515 High Similarity NPC476237
0.8511 High Similarity NPC104560
0.85 High Similarity NPC115862
0.85 High Similarity NPC81530
0.8485 Intermediate Similarity NPC235464
0.8485 Intermediate Similarity NPC471717
0.8485 Intermediate Similarity NPC103051
0.8485 Intermediate Similarity NPC316598
0.8485 Intermediate Similarity NPC166745
0.8469 Intermediate Similarity NPC328371
0.8469 Intermediate Similarity NPC151725
0.8469 Intermediate Similarity NPC122324
0.8469 Intermediate Similarity NPC7124
0.8469 Intermediate Similarity NPC106425
0.8454 Intermediate Similarity NPC8993
0.8447 Intermediate Similarity NPC475294
0.8438 Intermediate Similarity NPC473998
0.8438 Intermediate Similarity NPC26888
0.8438 Intermediate Similarity NPC475806
0.8438 Intermediate Similarity NPC470113
0.8421 Intermediate Similarity NPC214387
0.8421 Intermediate Similarity NPC309603
0.8421 Intermediate Similarity NPC473999
0.8421 Intermediate Similarity NPC128496
0.8404 Intermediate Similarity NPC128644
0.84 Intermediate Similarity NPC201406
0.84 Intermediate Similarity NPC477521
0.84 Intermediate Similarity NPC251680
0.84 Intermediate Similarity NPC327431
0.8396 Intermediate Similarity NPC475970
0.8384 Intermediate Similarity NPC99726
0.8384 Intermediate Similarity NPC474343
0.8384 Intermediate Similarity NPC208094
0.8381 Intermediate Similarity NPC16270
0.8367 Intermediate Similarity NPC134067
0.8367 Intermediate Similarity NPC469995
0.8367 Intermediate Similarity NPC470016
0.8367 Intermediate Similarity NPC476174
0.8367 Intermediate Similarity NPC279974
0.8367 Intermediate Similarity NPC174948
0.8367 Intermediate Similarity NPC293052
0.8367 Intermediate Similarity NPC84383
0.8367 Intermediate Similarity NPC139459
0.8367 Intermediate Similarity NPC317586
0.8367 Intermediate Similarity NPC318282
0.8367 Intermediate Similarity NPC209355
0.8367 Intermediate Similarity NPC173875
0.8365 Intermediate Similarity NPC472219
0.8365 Intermediate Similarity NPC472218
0.8365 Intermediate Similarity NPC220155
0.8365 Intermediate Similarity NPC472217
0.8351 Intermediate Similarity NPC152778
0.8351 Intermediate Similarity NPC214697
0.8351 Intermediate Similarity NPC162615
0.8351 Intermediate Similarity NPC205034
0.8351 Intermediate Similarity NPC139692
0.8349 Intermediate Similarity NPC473617
0.8349 Intermediate Similarity NPC473828
0.8333 Intermediate Similarity NPC175628
0.8333 Intermediate Similarity NPC78973
0.8333 Intermediate Similarity NPC111585
0.8333 Intermediate Similarity NPC112009
0.8333 Intermediate Similarity NPC95899
0.8333 Intermediate Similarity NPC232202
0.8333 Intermediate Similarity NPC310479
0.8333 Intermediate Similarity NPC148414
0.8333 Intermediate Similarity NPC222153
0.8333 Intermediate Similarity NPC182136
0.8333 Intermediate Similarity NPC180204
0.8318 Intermediate Similarity NPC122056
0.8317 Intermediate Similarity NPC303559
0.8316 Intermediate Similarity NPC472220
0.8316 Intermediate Similarity NPC473879
0.8316 Intermediate Similarity NPC97884
0.83 Intermediate Similarity NPC114274
0.83 Intermediate Similarity NPC477813
0.83 Intermediate Similarity NPC48647
0.83 Intermediate Similarity NPC98868
0.8298 Intermediate Similarity NPC322159
0.8298 Intermediate Similarity NPC473226
0.8298 Intermediate Similarity NPC325594
0.8298 Intermediate Similarity NPC82979
0.8283 Intermediate Similarity NPC234993
0.8283 Intermediate Similarity NPC249954
0.8283 Intermediate Similarity NPC16967
0.8283 Intermediate Similarity NPC473153
0.8283 Intermediate Similarity NPC472941
0.8283 Intermediate Similarity NPC456
0.8283 Intermediate Similarity NPC242848
0.8283 Intermediate Similarity NPC134072
0.8265 Intermediate Similarity NPC159410
0.8265 Intermediate Similarity NPC74751
0.8265 Intermediate Similarity NPC49670
0.8265 Intermediate Similarity NPC166906
0.8265 Intermediate Similarity NPC184870
0.8265 Intermediate Similarity NPC38830
0.8265 Intermediate Similarity NPC476186
0.8257 Intermediate Similarity NPC471854
0.8252 Intermediate Similarity NPC118911
0.8252 Intermediate Similarity NPC472868
0.8247 Intermediate Similarity NPC212948
0.8241 Intermediate Similarity NPC475163
0.8241 Intermediate Similarity NPC147912
0.8241 Intermediate Similarity NPC67259
0.8235 Intermediate Similarity NPC293753
0.8235 Intermediate Similarity NPC234892
0.8235 Intermediate Similarity NPC308726
0.8235 Intermediate Similarity NPC119601
0.8235 Intermediate Similarity NPC281702
0.8235 Intermediate Similarity NPC473163
0.8235 Intermediate Similarity NPC476081
0.8229 Intermediate Similarity NPC146554
0.8229 Intermediate Similarity NPC472240
0.8229 Intermediate Similarity NPC474704
0.8229 Intermediate Similarity NPC31985
0.8229 Intermediate Similarity NPC66344
0.8229 Intermediate Similarity NPC262858
0.8229 Intermediate Similarity NPC474889
0.8229 Intermediate Similarity NPC84271
0.8229 Intermediate Similarity NPC102414
0.8229 Intermediate Similarity NPC475921
0.8229 Intermediate Similarity NPC77168
0.8229 Intermediate Similarity NPC1015
0.8224 Intermediate Similarity NPC264634
0.8224 Intermediate Similarity NPC69291
0.8218 Intermediate Similarity NPC477720
0.8218 Intermediate Similarity NPC476303
0.8218 Intermediate Similarity NPC117685
0.8218 Intermediate Similarity NPC470074

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC266955 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.84 Intermediate Similarity NPD7639 Approved
0.84 Intermediate Similarity NPD7640 Approved
0.83 Intermediate Similarity NPD7638 Approved
0.8265 Intermediate Similarity NPD7748 Approved
0.8163 Intermediate Similarity NPD6399 Phase 3
0.8105 Intermediate Similarity NPD3618 Phase 1
0.8091 Intermediate Similarity NPD7115 Discovery
0.8061 Intermediate Similarity NPD6079 Approved
0.8061 Intermediate Similarity NPD7515 Phase 2
0.8041 Intermediate Similarity NPD5328 Approved
0.802 Intermediate Similarity NPD7902 Approved
0.8019 Intermediate Similarity NPD6881 Approved
0.8019 Intermediate Similarity NPD6899 Approved
0.8 Intermediate Similarity NPD6402 Approved
0.8 Intermediate Similarity NPD6675 Approved
0.8 Intermediate Similarity NPD5739 Approved
0.8 Intermediate Similarity NPD7128 Approved
0.7963 Intermediate Similarity NPD8130 Phase 1
0.7925 Intermediate Similarity NPD5697 Approved
0.7917 Intermediate Similarity NPD6409 Approved
0.7917 Intermediate Similarity NPD5330 Approved
0.7917 Intermediate Similarity NPD7146 Approved
0.7917 Intermediate Similarity NPD6684 Approved
0.7917 Intermediate Similarity NPD7334 Approved
0.7917 Intermediate Similarity NPD7521 Approved
0.7895 Intermediate Similarity NPD4786 Approved
0.789 Intermediate Similarity NPD8297 Approved
0.7879 Intermediate Similarity NPD7637 Suspended
0.7872 Intermediate Similarity NPD3667 Approved
0.787 Intermediate Similarity NPD7102 Approved
0.787 Intermediate Similarity NPD6883 Approved
0.787 Intermediate Similarity NPD7290 Approved
0.785 Intermediate Similarity NPD6011 Approved
0.785 Intermediate Similarity NPD7320 Approved
0.7843 Intermediate Similarity NPD6083 Phase 2
0.7843 Intermediate Similarity NPD6084 Phase 2
0.7798 Intermediate Similarity NPD6650 Approved
0.7798 Intermediate Similarity NPD6649 Approved
0.7798 Intermediate Similarity NPD6847 Approved
0.7798 Intermediate Similarity NPD6617 Approved
0.7798 Intermediate Similarity NPD6869 Approved
0.7778 Intermediate Similarity NPD6373 Approved
0.7778 Intermediate Similarity NPD6372 Approved
0.7778 Intermediate Similarity NPD6012 Approved
0.7778 Intermediate Similarity NPD6013 Approved
0.7778 Intermediate Similarity NPD6014 Approved
0.7767 Intermediate Similarity NPD4225 Approved
0.7757 Intermediate Similarity NPD5701 Approved
0.7755 Intermediate Similarity NPD6903 Approved
0.7755 Intermediate Similarity NPD6672 Approved
0.7755 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7755 Intermediate Similarity NPD5737 Approved
0.7745 Intermediate Similarity NPD5222 Approved
0.7745 Intermediate Similarity NPD5221 Approved
0.7745 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7727 Intermediate Similarity NPD6882 Approved
0.7723 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7723 Intermediate Similarity NPD7900 Approved
0.7714 Intermediate Similarity NPD5211 Phase 2
0.7714 Intermediate Similarity NPD7632 Discontinued
0.7708 Intermediate Similarity NPD3665 Phase 1
0.7708 Intermediate Similarity NPD3133 Approved
0.7708 Intermediate Similarity NPD3666 Approved
0.77 Intermediate Similarity NPD8035 Phase 2
0.77 Intermediate Similarity NPD8034 Phase 2
0.767 Intermediate Similarity NPD5173 Approved
0.7636 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7634 Intermediate Similarity NPD5784 Clinical (unspecified phase)
0.7629 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7624 Intermediate Similarity NPD5779 Approved
0.7624 Intermediate Similarity NPD5778 Approved
0.7624 Intermediate Similarity NPD4202 Approved
0.76 Intermediate Similarity NPD5785 Approved
0.7573 Intermediate Similarity NPD4697 Phase 3
0.757 Intermediate Similarity NPD5141 Approved
0.7551 Intermediate Similarity NPD5279 Phase 3
0.7525 Intermediate Similarity NPD5281 Approved
0.7525 Intermediate Similarity NPD5284 Approved
0.7525 Intermediate Similarity NPD6411 Approved
0.7524 Intermediate Similarity NPD5286 Approved
0.7524 Intermediate Similarity NPD4696 Approved
0.7524 Intermediate Similarity NPD5285 Approved
0.7522 Intermediate Similarity NPD6868 Approved
0.75 Intermediate Similarity NPD4752 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD4755 Approved
0.7476 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7476 Intermediate Similarity NPD5695 Phase 3
0.7453 Intermediate Similarity NPD5223 Approved
0.7449 Intermediate Similarity NPD5363 Approved
0.7449 Intermediate Similarity NPD1694 Approved
0.7429 Intermediate Similarity NPD5696 Approved
0.7423 Intermediate Similarity NPD5362 Discontinued
0.7391 Intermediate Similarity NPD6335 Approved
0.7383 Intermediate Similarity NPD5226 Approved
0.7383 Intermediate Similarity NPD5225 Approved
0.7383 Intermediate Similarity NPD5224 Approved
0.7383 Intermediate Similarity NPD4633 Approved
0.7358 Intermediate Similarity NPD4700 Approved
0.7353 Intermediate Similarity NPD5694 Approved
0.7353 Intermediate Similarity NPD6050 Approved
0.7347 Intermediate Similarity NPD3668 Phase 3
0.7345 Intermediate Similarity NPD4632 Approved
0.7339 Intermediate Similarity NPD6008 Approved
0.7328 Intermediate Similarity NPD7100 Approved
0.7328 Intermediate Similarity NPD7101 Approved
0.7327 Intermediate Similarity NPD4753 Phase 2
0.7327 Intermediate Similarity NPD7285 Clinical (unspecified phase)
0.7327 Intermediate Similarity NPD6101 Approved
0.7327 Intermediate Similarity NPD6904 Approved
0.7327 Intermediate Similarity NPD6673 Approved
0.7327 Intermediate Similarity NPD5764 Clinical (unspecified phase)
0.7327 Intermediate Similarity NPD6080 Approved
0.732 Intermediate Similarity NPD4269 Approved
0.732 Intermediate Similarity NPD4270 Approved
0.7315 Intermediate Similarity NPD5174 Approved
0.7315 Intermediate Similarity NPD5175 Approved
0.7304 Intermediate Similarity NPD6317 Approved
0.73 Intermediate Similarity NPD3573 Approved
0.7292 Intermediate Similarity NPD8259 Clinical (unspecified phase)
0.7255 Intermediate Similarity NPD5207 Approved
0.7255 Intermediate Similarity NPD5692 Phase 3
0.7245 Intermediate Similarity NPD6695 Phase 3
0.7245 Intermediate Similarity NPD7154 Phase 3
0.7241 Intermediate Similarity NPD6313 Approved
0.7241 Intermediate Similarity NPD6314 Approved
0.7217 Intermediate Similarity NPD6274 Approved
0.72 Intermediate Similarity NPD5786 Approved
0.72 Intermediate Similarity NPD4623 Approved
0.72 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD4519 Discontinued
0.7184 Intermediate Similarity NPD5693 Phase 1
0.7172 Intermediate Similarity NPD7338 Clinical (unspecified phase)
0.7156 Intermediate Similarity NPD4754 Approved
0.7155 Intermediate Similarity NPD6009 Approved
0.7143 Intermediate Similarity NPD5210 Approved
0.7143 Intermediate Similarity NPD4629 Approved
0.7143 Intermediate Similarity NPD4223 Phase 3
0.7143 Intermediate Similarity NPD4221 Approved
0.7129 Intermediate Similarity NPD7750 Discontinued
0.7128 Intermediate Similarity NPD8264 Approved
0.7119 Intermediate Similarity NPD6319 Approved
0.7117 Intermediate Similarity NPD6412 Phase 2
0.7113 Intermediate Similarity NPD5790 Clinical (unspecified phase)
0.7113 Intermediate Similarity NPD4252 Approved
0.7113 Intermediate Similarity NPD7525 Registered
0.71 Intermediate Similarity NPD5329 Approved
0.7083 Intermediate Similarity NPD7604 Phase 2
0.7059 Intermediate Similarity NPD6908 Approved
0.7059 Intermediate Similarity NPD6909 Approved
0.7059 Intermediate Similarity NPD6291 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD5208 Approved
0.7059 Intermediate Similarity NPD5983 Phase 2
0.7054 Intermediate Similarity NPD4729 Approved
0.7054 Intermediate Similarity NPD4730 Approved
0.7054 Intermediate Similarity NPD6686 Approved
0.7054 Intermediate Similarity NPD5168 Approved
0.7053 Intermediate Similarity NPD6117 Approved
0.7048 Intermediate Similarity NPD6001 Approved
0.7041 Intermediate Similarity NPD5369 Approved
0.7037 Intermediate Similarity NPD6404 Discontinued
0.703 Intermediate Similarity NPD6098 Approved
0.703 Intermediate Similarity NPD5280 Approved
0.703 Intermediate Similarity NPD4694 Approved
0.7027 Intermediate Similarity NPD4768 Approved
0.7027 Intermediate Similarity NPD4767 Approved
0.7025 Intermediate Similarity NPD7492 Approved
0.7021 Intermediate Similarity NPD6924 Approved
0.7021 Intermediate Similarity NPD6926 Approved
0.701 Intermediate Similarity NPD6929 Approved
0.7 Intermediate Similarity NPD4197 Approved
0.6992 Remote Similarity NPD7736 Approved
0.6991 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6989 Remote Similarity NPD7151 Approved
0.6989 Remote Similarity NPD7150 Approved
0.6989 Remote Similarity NPD7152 Approved
0.6979 Remote Similarity NPD6116 Phase 1
0.6975 Remote Similarity NPD6054 Approved
0.697 Remote Similarity NPD6435 Approved
0.6967 Remote Similarity NPD7507 Approved
0.6967 Remote Similarity NPD6616 Approved
0.6967 Remote Similarity NPD6336 Discontinued
0.6961 Remote Similarity NPD7524 Approved
0.6947 Remote Similarity NPD6942 Approved
0.6947 Remote Similarity NPD7339 Approved
0.6947 Remote Similarity NPD8039 Approved
0.6939 Remote Similarity NPD4695 Discontinued
0.6939 Remote Similarity NPD6930 Phase 2
0.6939 Remote Similarity NPD7514 Phase 3
0.6939 Remote Similarity NPD4822 Approved
0.6939 Remote Similarity NPD6931 Approved
0.6939 Remote Similarity NPD4821 Approved
0.6939 Remote Similarity NPD4820 Approved
0.6939 Remote Similarity NPD4819 Approved
0.6931 Remote Similarity NPD1696 Phase 3
0.693 Remote Similarity NPD5169 Approved
0.693 Remote Similarity NPD5134 Clinical (unspecified phase)
0.693 Remote Similarity NPD5249 Phase 3
0.693 Remote Similarity NPD5250 Approved
0.693 Remote Similarity NPD5247 Approved
0.693 Remote Similarity NPD4634 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data